コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rough up-regulation of uncoupling protein 3 (UCP3).
2 ochrome oxidase, as well as ATP synthase and UCP3.
3 ently mediated by an increased expression of UCP3.
4 enovirus-mediated overexpression of UCP1 and UCP3.
5 possible regulator of fatty acid metabolism, UCP3.
6 ough the uncoupling proteins UCP1, UCP2, and UCP3.
7 onductance through effects on UCP1, UCP2 and UCP3.
8 and they are transported by UCP1, UCP2, and UCP3.
9 suggesting tissue-specific effects of human UCP3.
10 of ROS is increased in mitochondria lacking UCP3.
11 thesize mRNA for the long isoform (UCP3L) of UCP3.
12 not associated with changes in expression of UCP3.
13 ther member of the uncoupling protein termed UCP3.
14 e-induced hyperthermia requires UCP1 but not UCP3.
15 and a C-->T silent polymorphism in exon 3 of UCP3.
16 ave cloned a third member of the UCP family, UCP3.
17 P2) without concomitant increases in UCP1 or UCP3.
18 -activated receptor-stimulated expression of UCP3.
19 nsulinemia in mice down-regulates myocardial UCP3.
20 ncreased glucose and palmitate oxidation and UCP3.
21 , is required to glutathionylate and inhibit UCP3.
22 A prevents hypoxia-mediated up-regulation of UCP3.
23 andidate regulatory factors that up-regulate UCP3.
25 oxidizing enzymes, and uncoupling protein 3 (UCP3), a thermogenic mitochondrial uncoupling protein.
26 in murine skeletal muscle, and expression of UCP3, AAC1, or AAC2, and PDH phosphorylation status did
29 infusion caused significant increases in the UCP3/actin mRNA ratio compared with saline-infused fed c
30 late but not pyruvate/malate), indicative of UCP3 activation by endogenous reactive oxygen species.
32 P3 Tg mice highlights that changes in muscle UCP3 activity can also affect other organ systems, presu
33 cid oxidation; however, the global impact of UCP3 activity on skeletal muscle and whole-body metaboli
35 ed increases in the metabolic genes PDK4 and UCP3 and also prevented fatty acid-mediated inhibition o
36 Early upregulation of mitochondrial genes (Ucp3 and Cpt1) and downregulation of key glycolytic gene
40 ypoxia robustly up-regulates skeletal muscle UCP3 and that the absence of UCP3 in primary skeletal my
42 the C75-induced increases of skeletal muscle UCP3 and whole body fatty acid oxidation and C75-induced
43 e oxidative capacity (Cpt1, Acox1, Cs, Cycs, Ucp3) and glucose metabolism (Glut1, Glut4, Hk2) was inc
45 carrier and decreased the activity of UCP1, UCP3, and complex III of the respiratory chain alongside
46 present knowledge regarding UCP1, UCP2, and UCP3, and review proposed functions for the two new unco
47 of UCP3, decreased in L littermates on GD60 (UCP3, APOB, ALDOB) or GD90 (PNPLA3, TF), albeit in the c
48 keletal muscle mRNA levels encoding UCP2 and UCP3 are correlated among individuals and may be coordin
50 ce that skeletal muscle mitochondria lacking UCP3 are more coupled (i.e. increased state 3/state 4 ra
56 doxycycline resulted in detectable levels of UCP3 at 12 h and 2.2-fold induction at 7 days compared w
61 ) was tightly bound to uncoupling protein 3 (UCP3), but this complex was disrupted in cells treated w
62 s is the first enzyme identified to regulate UCP3 by glutathionylation and is the first study on the
69 P<0.05), although muscle uncoupling protein (UCP3) content and maximal mitochondrial function were un
70 a twofold increase in uncoupling protein 3 (UCP3) content, ATP-to-O ratios and proton leak kinetics
71 iron metabolism increased or, in the case of UCP3, decreased in L littermates on GD60 (UCP3, APOB, AL
75 was the same between groups, indicating that UCP3 does not appear to function as a translocator for l
77 ite these effects on mitochondrial function, UCP3 does not seem to be required for body weight regula
87 we show that skeletal muscle-specific human UCP3 expression is able to significantly rescue LPS, but
88 iduals and may be coordinately regulated; 2) UCP3 expression is not regulated by differential effects
92 mechanism by which insulin inhibits cardiac UCP3 expression through activation of the lipogenic fact
93 al muscle and in brown fat, neither UCP2 nor UCP3 expression was affected by diet in A/J, B6, or KsJ
95 thyronine (T(3))-treated (model of increased UCP3 expression), and acute 2,4-dinitrophenol (DNP)-trea
96 hort periods of time, alters skeletal muscle UCP3 expression, affecting energy production and physica
99 l muscle and change in uncoupling protein 3 (UCP3) expression during the transition from the fed to f
104 ined the intron-exon structure for the human UCP3 gene and determined that UCP3S is generated when a
106 otide polymorphisms (SNPs) at the 70-kb UCP2-UCP3 gene cluster in relation to type 2 diabetes risk in
111 se kinase-4 (PDK4) and uncoupling protein-3 (UCP3), genes that are known to be involved in energy hom
115 ted by GDP (rats) or in the absence of UCP3 (ucp3(-/-)), H(2)O(2) emission was significantly (p < 0.0
117 to skeletal muscle and brown adipose tissue, UCP3 has been suggested to play important roles in regul
121 sly that mitochondrial uncoupling protein 3 (UCP3) improves functional recovery of the rodent heart d
124 evated lipid metabolism, yet the function of UCP3 in a physiological context remains controversial.
130 ating glucose metabolism, we expressed human UCP3 in L6 myotubes by adenovirus-mediated gene transfer
134 bolites that distinguish mice overexpressing UCP3 in muscle, both at rest and after exercise regimens
135 skeletal muscle UCP3 and that the absence of UCP3 in primary skeletal myocytes exacerbates hypoxia-in
138 herefore hypothesized that overexpression of UCP3 in skeletal muscle might protect against fat-induce
140 iochemistry/morphology and that induction of UCP3 in vivo mediates an increase in uncoupling activity
141 ason, we examined the expression of UCP2 and UCP3 in white adipose tissue and interscapular brown adi
143 nvestigate the role of uncoupling protein 3 (UCP3) in cardiac energy metabolism, cardiac O(2) consump
144 To clarify the role of uncoupling protein-3 (UCP3) in skeletal muscle, we used NMR and isotopic label
147 We identified nine sequence variants in UCP3, including Val9Met, Val102Ile, Arg282Cys, and a spl
150 68514- rs647126-rs1800006, spanning the UCP2-UCP3 intergenic and UCP3 regions) as significantly assoc
159 trast to UCP1, UCP2 is expressed widely, and UCP3 is expressed preferentially in skeletal muscle.
160 e recently cloned uncoupling protein homolog UCP3 is expressed primarily in muscle and therefore may
169 at expresses an epidermal-targeted keratin-5-UCP3 (K5-UCP3) transgene and exhibits significantly incr
172 beling experiments to evaluate the effect of UCP3 knockout (UCP3KO) in mice on the regulation of ener
177 uence of increased mitochondrial coupling in UCP3 KO mice on metabolism and the possible role of yet
184 ion, and mitochondrial uncoupling protein 3 (UCP3) levels, while increasing glycolysis, all of which
189 This seemingly paradoxical induction of UCP3 may be linked to the use of free fatty acid as a fu
190 that the investigation of the regulation of UCP3 may identify novel hypoxia-responsive regulatory pa
192 The newly described uncoupling protein 3 (UCP3) may make an important contribution to thermogenesi
193 n African American women, possibly linked to UCP3, may be implicated in their susceptibility to obesi
195 athionylation state of uncoupling protein-3 (UCP3) modulates the leak of protons back into the mitoch
196 ynthesis 3 h after stimulation but increased UCP3 mRNA 11.7-fold, whereas HFS had no significant effe
197 sociated with increased PGC-1alpha, UCP2 and UCP3 mRNA and decreased reactive oxygen species producti
198 onstrate that despite a 2-3-fold increase in UCP3 mRNA and protein expression in skeletal muscle duri
203 We have confirmed that a 10-fold increase in UCP3 mRNA levels occurs in rat quadriceps muscle between
209 inhibitor genistein abolished the effect of UCP3 on glucose uptake, and wortmannin inhibited UCP3-in
211 he addition of palmitate (known activator of UCP3) or under substrate conditions eliciting substantia
214 Male wild-type (WT) and muscle-specific UCP3-overexpressing transgenic (UCP3 Tg) C57BL/6J mice w
217 ariation in REE was seen for UCP1, UCP2, and UCP3 (p-55; exon 3a; and exon 3b) variants after adjustm
218 ) increased (isoform UCP2, p<0.0001; isoform UCP3, p=0.0036) and those of glucose transporter (GLUT4)
219 ssion of brown adipocyte-related genes UCP1, UCP3, PGC1alpha and PRDM16, as well as COX8B and ATP5B.
222 lipid metabolism (uncoupling protein [UCP]1, UCP3, PPAR gamma coactivator 1alpha [PGC-1alpha], and CD
224 oblasts following cotransfection of a murine UCP3 promoter-luciferase construct and myoD we identifie
225 of activation, and a significant increase of UCP3 protein expression was observed in this group.
229 00006, spanning the UCP2-UCP3 intergenic and UCP3 regions) as significantly associated with greater t
235 on caused increased muscle and decreased BAT UCP3, suggesting that muscle assumes a larger role in th
236 derivatives in skeletal muscle and plasma of UCP3 Tg mice (e.g., Asp, Glu, Lys, Tyr, Ser, Met) were s
237 d, oxoproline, Gly, and Glu) were altered in UCP3 Tg mice across all training and exercise conditions
238 l of 80 metabolites accurately discriminated UCP3 Tg mice from WT when modeled within a specific exer
239 select metabolites were altered in liver of UCP3 Tg mice highlights that changes in muscle UCP3 acti
240 of dehydrogenase activity were increased in UCP3 Tg mice, suggestive of a shift in tissue NADH/NAD(+
241 cle-specific UCP3-overexpressing transgenic (UCP3 Tg) C57BL/6J mice were compared with or without a 5
242 O, GNB3, INSIG2, LEPR, PPARG, TNF, UCP2, and UCP3) that had been previously reported to be associated
244 higher in adipose, heart (UCP2), and muscle (UCP3) tissues of mutant mice compared with those of the
246 results suggest a contribution from UCP2 (or UCP3) to variation in metabolic rate in young Pima India
248 ses an epidermal-targeted keratin-5-UCP3 (K5-UCP3) transgene and exhibits significantly increased cut
253 inhibited by GDP (rats) or in the absence of UCP3 (ucp3(-/-)), H(2)O(2) emission was significantly (p
255 C(2) cardiomyoblasts stably transfected with UCP3 under control of a tetracycline-repressible promoto
256 signaling does not modulate hypoxia-induced UCP3 up-regulation and neither does HIF-1alpha activatio
263 both short (UCP3S) and long (UCP3L) forms of UCP3, were highly correlated in individuals, indicating